A Newly Initiated Phase 1 Study Will Evaluate AIV007 for Wet AMD, DME 
Skitterphoto / Pixabay

A Newly Initiated Phase 1 Study Will Evaluate AIV007 for Wet AMD, DME 

  In late May 2023, clinical-stage biotechnology company AiViva Biopharma Inc. ("AiViva") shared via news release that the company had launched a Phase 1 clinical study evaluating AIV007 for diabetic…

Continue Reading A Newly Initiated Phase 1 Study Will Evaluate AIV007 for Wet AMD, DME 
Obeticholic Acid – Bezafibrate Combination Granted Orphan Drug Designation for Primary Biliary Cholangitis (PBC)
source: pixabay.com

Obeticholic Acid – Bezafibrate Combination Granted Orphan Drug Designation for Primary Biliary Cholangitis (PBC)

  In mid-May 2023, Pharmaceutical Technology reported that a new combination treatment had earned Orphan Drug designation. This combo? Obeticholic acid (OCA) and bezafibrate. Together, they represent a potential therapeutic…

Continue Reading Obeticholic Acid – Bezafibrate Combination Granted Orphan Drug Designation for Primary Biliary Cholangitis (PBC)
Kaftrio Saved Our Lives – Now We Are Fighting for Cystic Fibrosis Patients Around the World to Have the Same Chance
CF patient Nicole and her family

Kaftrio Saved Our Lives – Now We Are Fighting for Cystic Fibrosis Patients Around the World to Have the Same Chance

“Three years ago, my lung function was 11% and I was hours from death, then I received the gift of life – which was Trikafta.” These are the words of…

Continue Reading Kaftrio Saved Our Lives – Now We Are Fighting for Cystic Fibrosis Patients Around the World to Have the Same Chance
Rare Community Profiles: How the Seena Magowitz Foundation is Working to Change the World for People Living with Pancreatic Cancer
source: shutterstock.com

Rare Community Profiles: How the Seena Magowitz Foundation is Working to Change the World for People Living with Pancreatic Cancer

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: How the Seena Magowitz Foundation is Working to Change the World for People Living with Pancreatic Cancer
Palovarotene for FOP Receives Negative CHMP Opinion
https://pixabay.com/en/skeleton-hand-bones-anatomy-joint-778069/

Palovarotene for FOP Receives Negative CHMP Opinion

A positive opinion is needed from the Committee for Medicinal Products for Human Use (CHMP), part of the European Medicines Agency (EMA), to begin marketing a drug. Once a positive…

Continue Reading Palovarotene for FOP Receives Negative CHMP Opinion